Literature DB >> 24535884

Cytoskeleton changes of airway smooth muscle cells in juvenile rats with airway remodeling in asthma and the RhoA/ROCK signaling pathway mechanism.

B Wei1, Y X Shang2, M Li2, J Jiang3, H Zhang2.   

Abstract

This article aimed to investigate changes in the cytoskeleton of airway smooth muscle cells (ASMCs) in juvenile rats with airway remodeling in asthma. We further investigated the involvement of the RhoA/ROCK signaling pathway mechanism. Rat models of airway remodeling in asthma were established by antigen sensitization with ovalbumin for 2, 4, 6, and 8 weeks. The control group was treated with normal saline instead of ovalbumin. In the intervention group, after 8 weeks of culture, ASMCs were treated with the ROCK-specific inhibitor Y-27632. Immunofluorescence, real-time polymerase chain reaction, and Western blot analyses were used to observe changes in the cytoskeleton (F-actin and α-tubulin) of ASMCs and expressions of RhoA and ROCK. The asthmatic groups had significantly higher average gray values of F-actin in ASMCs compared to the control group (P < 0.01), and these values for the intervention group were significantly lower than those of the 8-week asthmatic group (P < 0.05). Expression levels of the α-tubulin protein in the asthmatic groups were all significantly higher than those of the control group (P < 0.01), and the levels in the intervention group were significantly reduced (P < 0.05). Expressions of RhoA and ROCK mRNA and proteins in all asthmatic groups were significantly higher than those of the control group (P < 0.01). Together, these results demonstrate substantial changes of the ASMC cytoskeleton and abnormal expressions of RhoA and ROCK mRNA and proteins in juvenile rats with airway remodeling in asthma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24535884     DOI: 10.4238/2014.January.22.2

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  14 in total

1.  Ras homolog family member A/Rho-associated protein kinase 1 signaling modulates lineage commitment of mesenchymal stem cells in asthmatic patients through lymphoid enhancer-binding factor 1.

Authors:  Xia Ke; Danh C Do; Changjun Li; Yilin Zhao; Marian Kollarik; Qingling Fu; Mei Wan; Peisong Gao
Journal:  J Allergy Clin Immunol       Date:  2018-09-05       Impact factor: 10.793

2.  miR-511-3p protects against cockroach allergen-induced lung inflammation by antagonizing CCL2.

Authors:  Danh C Do; Jie Mu; Xia Ke; Karan Sachdeva; Zili Qin; Mei Wan; Faoud T Ishmael; Peisong Gao
Journal:  JCI Insight       Date:  2019-10-17

3.  Biological characteristics of tracheal smooth muscle cells regulated by NK-1R in asthmatic rat with airway remodeling.

Authors:  Bing Wei; Yali Liu; Xiaozhe Yue; Yinping Li; Yunxiao Shang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  Neurokinin 1 receptor promotes rat airway smooth muscle cell migration in asthmatic airway remodelling by enhancing tubulin expression.

Authors:  Bing Wei; Mingwei Sun; Yunxiao Shang; Chao Zhang; Xuyong Jiao
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

5.  TH17 cells and corticosteroid insensitivity in severe asthma.

Authors:  Yan Xie; Peter W Abel; Thomas B Casale; Yaping Tu
Journal:  J Allergy Clin Immunol       Date:  2021-12-23       Impact factor: 10.793

6.  Atorvastatin has a protective effect in a mouse model of bronchial asthma through regulating tissue transglutaminase and triggering receptor expressed on myeloid cells-1 expression.

Authors:  Ming-Wei Liu; Rong Liu; Hai-Ying Wu; Mei Chen; Min-Na Dong; Yun-Qiao Huang; Chun-Hai Zhang; Yin-Zhong Wang; Jing Xia; Yang Shi; Feng-Mei Xie; Hua Luo; Xin-Yuan Zhao; Wei Wei; Mei-Xian Su
Journal:  Exp Ther Med       Date:  2017-06-09       Impact factor: 2.447

7.  Effect of Rho-kinase inhibition on complexity of breathing pattern in a guinea pig model of asthma.

Authors:  Saeed Pazhoohan; Mohammad Reza Raoufy; Mohammad Javan; Sohrab Hajizadeh
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

8.  Effect of Anti-IL17 Antibody Treatment Alone and in Combination With Rho-Kinase Inhibitor in a Murine Model of Asthma.

Authors:  Tabata M Dos Santos; Renato F Righetti; Leandro do N Camargo; Beatriz M Saraiva-Romanholo; Luciana R C R B Aristoteles; Flávia C R de Souza; Silvia Fukuzaki; Maria I C Alonso-Vale; Maysa M Cruz; Carla M Prado; Edna A Leick; Milton A Martins; Iolanda F L C Tibério
Journal:  Front Physiol       Date:  2018-09-05       Impact factor: 4.566

Review 9.  RhoA/Rho-kinases in asthma: from pathogenesis to therapeutic targets.

Authors:  Yan Zhang; Arjun Saradna; Rhea Ratan; Xia Ke; Wei Tu; Danh C Do; Chengping Hu; Peisong Gao
Journal:  Clin Transl Immunology       Date:  2020-04-29

10.  Rho-Associated Kinase Inhibitors: Potential Future Treatments for Glaucoma.

Authors:  Ramin Daneshvar; Nima Amini
Journal:  J Ophthalmic Vis Res       Date:  2014 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.